These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Plasmodium falciparum resistance to pyrimethamine and chlorproguanil -- host or parasite dependent? Björkman A; Brohult J; Sirleaf V; Willcox M; Bengtsson E Ann Trop Med Parasitol; 1980 Apr; 74(2):245-8. PubMed ID: 7002076 [No Abstract] [Full Text] [Related]
47. Enhanced sensitivity of P. falciparum to sulphalene as a consequence of resistance to pyrimethamine. Martin DC; Arnold JD Trans R Soc Trop Med Hyg; 1969; 63(2):230-5. PubMed ID: 4893738 [No Abstract] [Full Text] [Related]
48. In vitro demonstration of pyrimethamine resistance of "wild" Plasmodium falciparum in The Gambia. Smalley ME; Brown J Trans R Soc Trop Med Hyg; 1982; 76(3):324-8. PubMed ID: 7051453 [TBL] [Abstract][Full Text] [Related]
50. Pyrimethamine resistance in The Gambia: a failure to prevent experimental infection with Plasmodium falciparum in a "non-immune". Laing AB Trans R Soc Trop Med Hyg; 1972; 66(2):367-8. PubMed ID: 4558833 [No Abstract] [Full Text] [Related]
53. Some considerations on contemporary malaria research--contribution to discussion. Onori E Ann Ist Super Sanita; 1985; 21(3):337-9. PubMed ID: 3914851 [No Abstract] [Full Text] [Related]
54. Pyrimethamine-resistant strains of human malaria. Jones SA Trans R Soc Trop Med Hyg; 1968; 62(4):572. PubMed ID: 5671548 [No Abstract] [Full Text] [Related]
55. The effect of parasite populations on the curative action of pyrimethamine. Martin DC; Arnold JD Trans R Soc Trop Med Hyg; 1968; 62(3):379-84. PubMed ID: 4872957 [No Abstract] [Full Text] [Related]
56. High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana. Marks F; Evans J; Meyer CG; Browne EN; Flessner C; von Kalckreuth V; Eggelte TA; Horstmann RD; May J Antimicrob Agents Chemother; 2005 Mar; 49(3):1101-5. PubMed ID: 15728909 [TBL] [Abstract][Full Text] [Related]
57. [Detection of pyrimethamine resistance in P. falciparum long after discontinuation of its use]. Kuznetsov RL; Storey J; Kilama W; Pine D Med Parazitol (Mosk); 1984; (4):13-6. PubMed ID: 6384755 [No Abstract] [Full Text] [Related]
58. [Effectiveness of treatment with chloroquine, fansidar and dabequin of Plasmodium falciparum carriers, residing in a hyperendemic focus of malaria (the city of Bagamoyo, Northeastern Tanzania)]. Kuznetsov RL; Kilama V; Peĭn D; Kampbell SS; Stori D Med Parazitol (Mosk); 1985; (4):15-9. PubMed ID: 3903459 [No Abstract] [Full Text] [Related]
59. A case of fansidar-resistant Plasmodium falciparum from Tanzania. De Geus A; Meuwissen JH; van Rijn A Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245 [No Abstract] [Full Text] [Related]
60. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea. Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]